Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Noort, V. van der
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(34)
+
-
Availability
Open access
(24)
+
-
Metadata Only
(11)
+
-
Creation Date
2021
(10)
+
-
2022
(8)
+
-
2023
(7)
+
-
2018
(3)
+
-
2016
(2)
+
-
2019
(2)
+
-
2020
(2)
+
-
Show more
Faculty
Leiden University Medical Center (LUMC)
(24)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(24)
+
-
Scholarly Publications
(11)
+
-
Topic
Immunotherapy
(3)
+
-
Outcome
(3)
+
-
6 inhibitors
(2)
+
-
CDK4
(2)
+
-
Docetaxel
(2)
+
-
Erlotinib
(2)
+
-
Malignant pleural mesothelioma
(2)
+
-
Non-small cell lung cancer
(2)
+
-
Precision medicine
(2)
+
-
Prostate cancer
(2)
+
-
Show more
Author
Noort, V. van der
(35)
+
-
Smit, E.F.
(13)
+
-
Baas, P.
(8)
+
-
Gelderblom, H.
(8)
+
-
Jansen, A.M.L.
(7)
+
-
Roepman, P.
(7)
+
-
Verheul, H.M.W.
(7)
+
-
Voest, E.E.
(7)
+
-
Zeverijn, L.J.
(7)
+
-
Hartemink, K.J.
(6)
+
-
Henegouwen, J.M.V.
(6)
+
-
Hoes, L.R.
(6)
+
-
Wijngaart, H. van der
(6)
+
-
Dickhoff, C.
(5)
+
-
Joosten, P.J.M.
(5)
+
-
Kerver, E.D.
(5)
+
-
Klomp, H.M.
(5)
+
-
Langen, A.J. de
(5)
+
-
Leng, W.W.J. de
(5)
+
-
Monkhorst, K.
(5)
+
-
Veenhof, A.A.F.A.
(5)
+
-
Burgers, J.A.
(4)
+
-
Diessen, J.N.A. van
(4)
+
-
Gooijer, C.J. de
(4)
+
-
Groot, J.W.B. de
(4)
+
-
Heuvel, M.M. van den
(4)
+
-
Hoeben, A.
(4)
+
-
Velden, D.L. van der
(4)
+
-
Werkhoven, E. van
(4)
+
-
Dahele, M.
(3)
+
-
Geurts, B.S.
(3)
+
-
Groen, H.J.M.
(3)
+
-
Haanen, J.B.A.G.
(3)
+
-
Hendriks, M.P.
(3)
+
-
Herpen, C.M.L. van
(3)
+
-
Huitema, A.D.R.
(3)
+
-
Jebbink, M.
(3)
+
-
Labots, M.
(3)
+
-
Leeuwen, F.W.B. van
(3)
+
-
Muller, M.
(3)
+
-
Peters, D.
(3)
+
-
Stigt, J.A.
(3)
+
-
Wekken, A.J. van der
(3)
+
-
Wit, G.F. de
(3)
+
-
Aerts, J.G.
(2)
+
-
Aerts, J.G.J.V.
(2)
+
-
Badrising, S.K.
(2)
+
-
Bahce, I.
(2)
+
-
Beerepoot, L.V.
(2)
+
-
Berg, H.P. van den
(2)
+
-
Berg, N.S. van den
(2)
+
-
Bergman, A.M.
(2)
+
-
Biesma, B.
(2)
+
-
Bootsma, G.P.
(2)
+
-
Brekel, M.W.M. van den
(2)
+
-
Broeks, A.
(2)
+
-
Brouwer, O.R.
(2)
+
-
Buma, A.I.G.
(2)
+
-
Coenen, J.L.L.M.
(2)
+
-
Cornelissen, R.
(2)
+
-
Cuppen, E.
(2)
+
-
Dammeijer, F.
(2)
+
-
Eertwegh, A.J.M. van den
(2)
+
-
Erdkamp, F.
(2)
+
-
Farzan, N.
(2)
+
-
Gort, E.H.
(2)
+
-
Graaf, W.T.A. van der
(2)
+
-
Groot, D.J. de
(2)
+
-
Haanen, J.B.
(2)
+
-
Haar, J. van de
(2)
+
-
Hamberg, P.
(2)
+
-
Hooijberg, E.
(2)
+
-
Jong, I.J. de
(2)
+
-
KleinJan, G.H.
(2)
+
-
Klop, W.M.C.
(2)
+
-
Lalezari, F.
(2)
+
-
Leng, W.J. de
(2)
+
-
Lolkema, M.P.
(2)
+
-
Lubeck, Y.
(2)
+
-
M. los
(2)
+
-
Morreau, H.
(2)
+
-
Olmos, R.A.V.
(2)
+
-
Oort, I.M. van
(2)
+
-
Poel, H.G. van der
(2)
+
-
Sanders, J.
(2)
+
-
Schumacher, T.N.
(2)
+
-
Seignette, I.M.
(2)
+
-
Sterk, P.J.
(2)
+
-
Vogel, W.V.
(2)
+
-
Voorthuizen, T. van
(2)
+
-
Vos, F.Y.F.L. de
(2)
+
-
Vries, R. de
(2)
+
-
Vrijaldenhoven, S.
(2)
+
-
Wolf-Lansdorf, M.
(2)
+
-
Show more
Language
en
(35)
+
-
Search results
(1 - 24 of 35)
Pages
1
2
›
››
show grid
show list
save search
Efficacy and safety of panitumumab in patients with RAF/RAS-wild-type glioblastoma
Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials
Patients with rare cancers in the drug rediscovery protocol (DRUP) benefit from genomics-guided treatment
Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancer
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours
Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19)
Sentinel node procedure to select clinically localized prostate cancer patients with occult nodal metastases for whole pelvis radiotherapy
PD-1T TILs as a predictive biomarker for clinical benefit to PD-1 blockade in patients with advanced NSCLC
Immune cells in mesothelioma microenvironment simplistic marker of response to nivolumab plus ipilimumab?
Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus intercalated TKI with chemotherapy for EGFR-mutated nonsmall cell lung cancer
Neoadjuvant nivolumab + T-VEC combination therapy for resectable early stage or metastatic (IIIB-IVM1a) melanoma with injectable disease: study protocol of the NIVEC trial
Trastuzumab and pertuzumab combination therapy for advanced pre-treated HER2 exon 20-mutated non-small cell lung cancer
Patients with rare cancers in the Drug Rediscovery Protocol (DRUP) benefit from genomics-guided treatment
Ritonavir-boosted exposure of kinase inhibitors
Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancer
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma
eNose analysis for early immunotherapy response monitoring in non-small cell lung cancer (vol 160, pg 36, 2021)
Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer
The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer
Prognostic value of CYFRA 21.1 in malignant mesothelioma: A brief report of the randomized phase II trial NVALT19
The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer
Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma
Technologic (r)evolution leads to detection of more sentinel nodes in patients with melanoma in the head and neck region
eNose analysis for early immunotherapy response monitoring in non-small cell lung cancer
Pages
1
2
›
››